Biodot Response To Covid 19 Biodot

BioDot Response To COVID-19 - BioDot

BioDot Response To COVID-19 - BioDot The spread of covid 19 has brought significant challenges to our global community, including unprecedented pressure on healthcare providers and manufacturers. thank you for your work and dedication during this difficult time. we would like to update you on our product availability. Unlike medical professionals and grocers who are our frontline fighters, pe backed companies like biodot are going after covid 19 from behind the scenes.

BioDot Supports COVID-19 Test Manufacturers Globally - BioDot

BioDot Supports COVID-19 Test Manufacturers Globally - BioDot To support increasing demand globally for covid 19 testing, biodot has compressed production times for most new lateral flow dispensing platforms from months to weeks. Worldwide, more than 50 companies are producing or developing covid 19 antibody tests using biodot technology. “as the diagnostics and lab automation markets continue to grow, due in large part to the covid 19 pandemic, companies will require transformative technology to help them move toward commercialization faster,” said anthony lemmo, ceo of biodot, who will continue to serve in this role. Biodot's products were featured on a bbc piece about manufacturing rapid covid 19 tests.to learn more, visit biodot at https://www.biodot.com/ .

BioDot Accelerates Manufacturing To Help Customers Meet Global COVID-19 Testing Demand | BioDot

BioDot Accelerates Manufacturing To Help Customers Meet Global COVID-19 Testing Demand | BioDot “as the diagnostics and lab automation markets continue to grow, due in large part to the covid 19 pandemic, companies will require transformative technology to help them move toward commercialization faster,” said anthony lemmo, ceo of biodot, who will continue to serve in this role. Biodot's products were featured on a bbc piece about manufacturing rapid covid 19 tests.to learn more, visit biodot at https://www.biodot.com/ . Biodot's president tony lemmo was featured in pharma's almanac article in response to "the greatest lesson learned from the covid 19 pandemic.". In conjunction with the implementation of artemis’ value creation plan, biodot’s leadership and employee base adapted seamlessly to supply chain bottlenecks, 24 hour productions schedules, and coronavirus restrictions to meet a seemingly unending demand. Health officials warn that balance is needed to ensure covid 19 testing efforts continue even as the country pushes for more coronavirus vaccinations…. Biodot's automated dispensing platforms are used by diagnostics manufacturers to produce high quality covid 19 tests rapidly and at a scale, and these companies are responsible for regulatory approvals and distribution to the point of care.

BioDot CellWriter